What is Ibex?
Revolutionizing Cancer Diagnosis with Intelligent Precision
How to use Ibex?
Discover how clinicians integrate Ibex seamlessly into pathology workflows—watch our onboarding demo to see real-time AI assistance in action.
Table of contents
Ibex
Ibex: AI Tool for Cancer Care Diagnostics
Ibex: AI-powered diagnostic solutions for cancer care—an advanced ai tool transforming oncology. Ibex delivers precision, speed, and reliability.
🟢
Ibex - Introduction
🟢
Ibex - Key Features
Key Features From Ibex
Real-time AI-assisted tumor identification
FDA-cleared and peer-validated diagnostic performance
Interoperable integration with existing LIS and digital pathology platforms
Ibex's Use Cases
Pathologists leveraging AI for second-opinion confidence and diagnostic consistency
Oncology networks deploying Ibex at scale to reduce time-to-diagnosis and improve treatment planning
-
Ibex Support Email & Customer Service Contact & Refund Policy
For technical support, billing inquiries, or refund requests, visit the contact us page (https://ibex-ai.com/contact/)
-
Ibex Company
Ibex Company name: Ibex Medical Analytics Ltd.
Learn about our mission, clinical partnerships, and regulatory milestones at the about us page (https://ibex-ai.com/about/).
-
Ibex LinkedIn
Follow our latest clinical updates and thought leadership: https://www.linkedin.com/company/ibexmedicalanalytics/
-
Ibex X (formerly Twitter)
Stay updated on product releases and oncology AI insights: https://twitter.com/IbexMedAx
🟢
Ibex - Frequently Asked Questions
FAQ from Ibex
What is Ibex?
Revolutionizing Cancer Diagnosis with Intelligent Precision
How to use Ibex?
Our intuitive, browser-based platform requires no specialized hardware—simply upload digitized slides or connect via PACS/LIS; AI analysis begins instantly with clinician-in-the-loop validation.
How accurate are Ibex's diagnostic solutions?
Ibex's algorithms are validated across multi-center studies and demonstrate sensitivity and specificity exceeding 95% for key cancer subtypes—including prostate, breast, and colorectal cancers—with regulatory clearance in the US, EU, and Israel.
Who uses Ibex's AI platform?
Leading academic medical centers, community hospitals, reference labs, and global diagnostics partners rely on Ibex to augment pathology expertise, standardize reporting, and accelerate precision oncology pathways.
What are the benefits of using Ibex?
Reduced diagnostic turnaround time, decreased inter-observer variability, actionable biomarker insights, seamless EHR integration, and measurable improvements in case throughput—without compromising clinical autonomy.